Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming
- PMID: 36669113
- PMCID: PMC9942853
- DOI: 10.1073/pnas.2213810120
Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming
Abstract
Reactivation of the inactive X chromosome is a hallmark epigenetic event during reprogramming of mouse female somatic cells to induced pluripotent stem cells (iPSCs). This involves global structural remodeling from a condensed, heterochromatic into an open, euchromatic state, thereby changing a transcriptionally inactive into an active chromosome. Despite recent advances, very little is currently known about the molecular players mediating this process and how this relates to iPSC-reprogramming in general. To gain more insight, here we perform a RNAi-based knockdown screen during iPSC-reprogramming of mouse fibroblasts. We discover factors important for X chromosome reactivation (XCR) and iPSC-reprogramming. Among those, we identify the cohesin complex member SMC1a as a key molecule with a specific function in XCR, as its knockdown greatly affects XCR without interfering with iPSC-reprogramming. Using super-resolution microscopy, we find SMC1a to be preferentially enriched on the active compared with the inactive X chromosome and that SMC1a is critical for the decompacted state of the active X. Specifically, depletion of SMC1a leads to contraction of the active X both in differentiated and in pluripotent cells, where it normally is in its most open state. In summary, we reveal cohesin as a key factor for remodeling of the X chromosome from an inactive to an active structure and that this is a critical step for XCR during iPSC-reprogramming.
Keywords: X chromosome; X-inactivation; X-reactivation; cellular reprogramming; cohesin.
Conflict of interest statement
J.T.L. is a cofounder of Fulcrum Therapeutics and is also a scientific advisor to Skyhawk Therapeutics. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Lyon M. F., Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190, 372–373 (1961). - PubMed
-
- Payer B., Lee J. T., X chromosome dosage compensation: How mammals keep the balance. Annu. Rev. Genet. 42, 733–772 (2008). - PubMed
-
- Payer B., Developmental regulation of X-chromosome inactivation. Semin. Cell Dev. Biol. 56, 88–99 (2016). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
